|
|
Post by cjm18 on Jun 20, 2017 10:46:01 GMT -5
The company chose to cut the burn rate from 10 to 7 million per month based on future expectations. They would have cut it more if they thought they needed to. Point being if they thought they could avoid dilution by cutting the burn rate then I guess that's what they would do. Hopefully they did cut it enough.
|
|
|
|
Post by orlon on Jun 20, 2017 10:52:06 GMT -5
Any further dilution would virtually make this stock worthless. I feel we're going around in circles by pushing the ideas of hope further down the timeline and profitability offshore. What started out as a great discovery and benefit to many diabetics has essentially been killed off. Pessimistic viewpoint? Perhaps...but based on reality.
|
|
|
|
Post by deaner3 on Jun 20, 2017 10:54:49 GMT -5
All that is really needed is for one of these to take off
Sales in USA (as you can see from revenue it is increasing and I'm looking forward to this Friday. It will be a good sign )
UAE deal?
Locust deal for technosphere product
Va deal (won't show scripts but huge potential with this)
Down the road Brazil and other things.
Not to mention partnerships etc.
I've never been more bullish than right now.
|
|
|
|
Post by brotherm1 on Jun 20, 2017 11:30:15 GMT -5
Any further dilution would virtually make this stock worthless. I feel we're going around in circles by pushing the ideas of hope further down the timeline and profitability offshore. What started out as a great discovery and benefit to many diabetics has essentially been killed off. Pessimistic viewpoint? Perhaps...but based on reality. Based upon your perception of reality |
|
|
|
Post by casualinvestor on Jun 20, 2017 11:30:24 GMT -5
Any further dilution would virtually make this stock worthless. I feel we're going around in circles by pushing the ideas of hope further down the timeline and profitability offshore. What started out as a great discovery and benefit to many diabetics has essentially been killed off. Pessimistic viewpoint? Perhaps...but based on reality. Worthless? While this stock has been pushed down quite a bit by various factors, it is far from worthless. We all know what great results people who use Afrezza properly have. And if (for example) 20% more shares are issued to extend the runway by whatever 25-30 million dollars get, it will still be far from worthless. For the past few years, the stock has been a gamble. And a 20% smaller return is just a change in the long-term odds. Short term bad news (aka dillution) can be a good buy-in point or averaging down point. It all depends on if you feel like gambling |
|
|
|
Post by myocat on Jun 20, 2017 11:36:57 GMT -5
I like the negative sentiments here. It helps me playing my non-core positions.
|
|
